Founded
Address
Venrock Associates
55 Cambridge Parkway
Suite 100
Cambridge, MA 02142
United States
Venrock Associates
Palo Alto, CA 00000
United States
Phone
Website
Sector
Industry
Recent investment activity
KANDO id: 32106
Corporate information
Registration country
Company type
The venture capital arm of the Rockefeller Family.Funds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| Venrock Associates VIII LP | Venture | 2017 | USD | 450,000,000 |
| Venrock Associates VII LP | Venture | 2014 | USD | 450,000,000 |
| Venrock Healthcare Capital Partners II LP | Venture | 2014 | ||
| Venrock Associates VI LP | Venture | 2010 | ||
| Venrock Partners VI LP | Venture | 2010 |
Funding rounds
Investment preferences
Minimum investment (USD)
2,000,000
Maximum initial investment (USD)
40,000,000
Investment size comment
USD 10 million sweet spot.
Stage focus
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 283| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
|
10x Genomics | Genomics sequencing company. | Series C Follow-on investment | |||
|
2Wire Inc | Provides broadband products, software and services that enable an integrated triple play of networked data, voice and media services. | N/A | |||
|
3Com Corp | Networking systems for enterprises, networking service providers, small businesses and individuals. | N/A Initial investment | |||
|
3Dfx Interactive | Family of high-performance graphics subsystems company for real-time 3-D images. | N/A Initial investment | |||
|
6sense Insights Inc | Predictive intelligence platform for marketing and sales. | Series C | |||
|
|
6sense Insights Inc | Predictive intelligence platform for marketing and sales. | Series B | |||
|
|
6sense Insights Inc | Predictive intelligence platform for marketing and sales. | Series A led the round | |||
|
Acadia Pharmaceuticals Inc | Small molecule drug discovery and development company. | Venture | |||
|
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series F Follow-on investment | |||
|
|
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series E Follow-on investment | |||
|
|
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series C Follow-on investment | |||
|
|
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series B Follow-on investment | |||
|
|
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series A Initial investment | |||
|
Achaogen Inc | Develops solutions to the problem of drug resistance | N/A Initial investment | |||
|
Adavium Medical | N/A Initial investment | ||||
|
Adify Corp | N/A Initial investment | ||||
|
Adnexus Therapeutics Inc | A biotechnology company focused on developing new class of therapeutic compounds. | N/A Initial investment | |||
| ADVANCE Medical Inc | N/A | |||||
| Airspan Networks Inc | N/A Initial investment | |||||
| Alimera Sciences Inc | Biopharmaceutical company. | Series B Initial investment | ||||
|
Allux Medical Inc | Medical device company developing medical devices for the treatment of hyper-reactive airway mucosa. | N/A Initial investment | |||
| American Superconductor Corp | N/A | |||||
|
Anacor Pharmaceuticals Inc | Series E Initial investment | ||||
|
|
Anacor Pharmaceuticals Inc | Series C Initial investment led the round | ||||
| Anadys Pharmaceuticals Inc | N/A |
Team
Former team members
| Employee | Company | Position | ||
|---|---|---|---|---|
| Ray Rothrock | Luminari Capital | |||
|
Marissa Campise | Rucker Park Capital | ||
|
|
Marissa Campise | Greycroft Partners LLC |